Saudi German Health leads in region with ACHSI accreditation for 30 Centres of Excellence - Middle East Business News and Information
Saudi German Health (SGH), one of the leading healthcare providers in the region, received accreditation from the Australian Council on Healthcare Standards International (ACHSI) for 18 new Centres of Excellence across its hospitals in Saudi Arabia. This addition represents an exceptional milestone for SGH, raising the total number of accredited centres to 30, the highest in the region.
The newly accredited centres specialise in emergency medicine, diagnostics, interventional radiology, and outpatient surgeries. This achievement underscores SGH's steadfast commitment to providing medical excellence, innovation, and patient-centred care in alignment with Saudi Vision 2030.
Dr. Ahmed Shebl, Group CEO of Saudi German Health, said: 'Receiving ACHSI accreditation for 18 additional Centres of Excellence is a testament to our commitment to elevating healthcare standards across the region. With 30 accredited Centres of Excellence now under our management, we are reinforcing our leading position in the healthcare sector by prioritising patient-focused services and maintaining exceptional medical standards. This achievement aligns with our guiding principle of 'Caring like Family' to continually enhance patient outcomes through accessible and innovative healthcare solutions.'
With an extensive network of 22 medical facilities across the Middle East and North Africa, more than 3,900 beds across all hospitals and over 9,000 dedicated employees, SGH continues investing in cutting-edge medical advancements, international partnerships, and ongoing education to enhance healthcare excellence. The organisation's strong commitment to value-based healthcare (VBHC) ensures optimised healthcare resources and improved patient satisfaction.
Moreover, SGH has established itself as a cornerstone of regional healthcare with its 35 years of industry excellence. It provides world-class care to over 2.5 million patients annually across 44 medical specialties. This new accreditation further reinforces its long-standing industry leadership in fostering healthcare innovation and transformation.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mid East Info
27-05-2025
- Mid East Info
To support innovation in digital healthcare in Saudi Arabia Bupa CareConnect signs 4 global strategic partnerships
Under the patronage of the Ministry of Health and Seha Virtual Hospital, and in the presence of prominent leaders and experts in healthcare, innovation, and technology from around the world, Bupa CareConnect, the Kingdom's leading cooperative health insurance provider, announced the signing of four strategic partnership agreements with global health tech companies: GOQii, Comarch, Nuralogix, and We Healthify. These partnerships aim to expand the scope of digital services and enhance the quality of healthcare for members within the Kingdom. The announcement came during its participation as a Gold Sponsor at the (6th MENA Telehealth & Virtual Care Expo 2025), which was recently held in Riyadh. These partnerships and sponsorship of the conference come following Bupa CareConnect's recent receipt of two prestigious awards from the Council of Health Insurance: 'Digital Innovation for Private Sector Providers' and 'Innovative Sustainability for Private Sector Providers.' Bupa CareConnect was recognized as the first private sector provider to receive these honors, reflecting its position as a key driver of innovation and digital transformation in Saudi Arabia's healthcare sector. Digital Health: Bupa Arabia showcased a range of its innovative digital solutions during the conference through its healthcare delivery arm, Bupa CareConnect, most notably the Digital Clinic Pod, AI-powered intelligent care services, in addition to its integrated digital application. On the second day of the conference, Dr. Abdullah Khafagy, Executive Medical Director at Bupa CareConnect, participated as a keynote speaker in a session titled 'Managing Virtual Care for Chronic Conditions,' during which he reviewed Bupa Arabia's experience in improving patients' lives using advanced digital technologies. He highlighted the 'Bupa Pro' program, which eliminated the need for prior medical approvals, contributing to faster access to care and enhancing the patient experience. Khafagy emphasized that its participation in the Virtual Healthcare Conference affirms its commitment to supporting digital transformation in the healthcare sector, aligned with Saudi Vision 2030. He expressed pride in offering an integrated care model focused on easy access to healthcare services and delivering the highest quality treatment, while harnessing modern technologies such as artificial intelligence to predict medical conditions and provide proactive responses that ensure prevention and improve health outcomes. Human Care: Tal Nazer, CEO of Bupa Arabia said:'At Bupa Arabia, our vision is to redefine the future of healthcare through continuous innovation, global partnerships, and a patient-first approach. These international collaborations are a key step in fulfilling our promise to deliver world-class healthcare solutions to the Kingdom.' Nazer added: 'Our international partnerships with leading health technology pioneers reflect our commitment to delivering world-class healthcare solutions within the Kingdom, as we believe the optimal healthcare experience is one that balances technological advancement with a human touch.' Strategic Partner: This conference is considered a leading regional platform to drive digital transformation in the healthcare sector and to promote the adoption of value-based virtual care models. It also represents an important opportunity to expand frameworks for international cooperation, exchange expertise, and explore innovative health solutions. This is supported by prestigious international organizations such as the World Health Organization, the World Bank, the World Trade Organization, and the American Telemedicine Association. Bupa CareConnect's participation in the conference reflects its role as a strategic partner in the digital transformation journey of the national healthcare sector, striving to provide more sustainable and integrated care that contributes to improving quality of life and advancing digital transformation in the sector.
Mid East Info
15-05-2025
- Mid East Info
Robotic Liver Transplants at KFSHRC Now Extended to Children - Middle East Business News and Information
Riyadh: When technological precision meets the compassion of medicine, healing becomes a story worth telling. This is what unfolded at King Faisal Specialist Hospital & Research Centre (KFSHRC) Riyadh, where an eight-year-old child underwent a life-saving liver lobe transplant using an advanced robotic surgical system, after liver failure had exhausted his small body and deprived him of his childhood. The high-precision technology enabled the young patient to be discharged just two weeks after surgery, half the usual recovery time, allowing him to return to a normal childhood. The medical team described the outcome as the essence of their striving to achieve. The child's condition required urgent intervention, complicated by the small body size and the limited space available for surgical access. However, KFSHRC's extensive experience with robotic organ transplants in adults paved the way for adapting the technology to a paediatric case. A tailored surgical plan was developed, involving precisely repositioning the robotic instrument entry points to accommodate the child's anatomy. Professor Dieter Broering, Executive Director of the Organ Transplant Centre of Excellence and lead surgeon on the case, explained : 'Robotic surgical techniques have traditionally been limited to adults, but we succeeded in adapting them for children, offering exceptional precision and a marked reduction in complications. The transplant required redesigning the surgical approach to suit the child's small body and confined space, which we addressed by meticulously adjusting the entry sites for the robotic tools to ensure maximum safety.' The procedure was successfully performed by extracting the left lobe from a living donor and fully transplanting it into the child, using a robotic surgical system, without any direct manual intervention. This approach significantly minimized the size of surgical incisions. It accelerated the recovery process, allowing the child to be discharged within two weeks, compared to the usual month-long hospital stay for similar transplants. This operation represents a ground-breaking model for expanding robotic surgery in paediatric care. The technology offers exact control, reduces surgical complications, and enhances overall safety, paving the way for the future development of child-specific robotic surgical systems. This achievement is part of a series of milestones positioning KFSHRC as a global leader in robotic surgery. The hospital previously performed the world's first fully robotic heart transplant and the world's first robotic liver transplant—advancements that garnered attention from both local and international media. These breakthroughs reflect KFSHRC's commitment to pioneering innovative medical solutions and delivering world-class specialized healthcare. The accomplishment also represents a success of the Health Sector Transformation Program, one of the key initiatives under Saudi Vision 2030, launched by H.R.H Crown Prince Mohammed bin Salman, Prime Minister of the Kingdom. It stands as a testament to the quality of healthcare provided to all people in Saudi Arabia. It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 15th globally in the list of the world's top 250 Academic Medical Centres for the third consecutive year and recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, it was included in Newsweek magazine's World's Best Smart Hospitals list for 2025.
Mid East Info
09-05-2025
- Mid East Info
MOU between the Saudi Society of Dermatology and Dermatologic Surgery (SSDDS) and Sanofi - Middle East Business News and Information
Saudi Society of Dermatology and Sanofi Sign MoU to Advance Dermatological Care in Saudi Arabia Riyadh, KSA –May 2025 – The Saudi Society of Dermatology and Dermatologic Surgery (SSDDS), the leading professional organization for dermatologists in Saudi Arabia, has signed a Memorandum of Understanding (MoU) with Sanofi, a global leader in innovative healthcare. This strategic partnership aims to enhance dermatological care in the Kingdom and aligns with the goals of Saudi Vision 2030 to promote innovation and excellence in healthcare. The MoU signifies a collaborative effort to strengthen the role of SSDDS through active partnerships between public and private sectors. The agreement will focus on improving care for chronic and immunological skin diseases—particularly Type 2 inflammatory conditions like atopic dermatitis, which affects up to 20% of children in Saudi Arabia. According to the Ministry of Health, dermatological conditions are among the top reasons for specialist clinic visits, with around 12% of primary healthcare center patients experiencing skin-related issues. Common conditions include atopic dermatitis, psoriasis, acne, and infectious diseases. These disorders often carry a significant psychological and social burden, especially among youth. The rise in allergic skin conditions due to environmental and climatic factors further highlights the need for heightened awareness and innovative treatment approaches. The MoU signing ceremony was attended by key stakeholders from the healthcare sector and Sanofi representatives. Dr. Abdullah Al-Akeel, President of SSDDS, commented: 'We are excited to launch this partnership with Sanofi. This collaboration will support medical education, promote scientific research, and enhance clinical practices across the Kingdom. It will empower Saudi dermatologists to remain at the forefront of global advancements and deliver optimal care to their patients.' Preeti Futnani, MCO Lead and Specialty Care General Manager for Greater Gulf at Sanofi, added: 'At Sanofi, we believe that strong partnerships with national scientific bodies are key to sustainable innovation. Through our collaboration with SSDDS, we aim to expand access to advanced treatments and strengthen patient support programs such as 'My Journey with Dupilumab,' ultimately improving patient outcomes and experiences.' As part of the partnership, SSDDS and Sanofi will jointly launch certified training programs, organize scientific conferences, and conduct specialized workshops. The initiative also includes public awareness campaigns and a focus on digital transformation to improve diagnostic capabilities and healthcare service delivery. This landmark agreement underscores the shared commitment of SSDDS and Sanofi to improving dermatological health and building a more resilient, innovative healthcare ecosystem in Saudi Arabia.
